- If you qualify for and participate in the study, you will be randomly assigned to receive either the investigational drug or placebo via subcutaneous injection into the skin.
- To help keep the study results as accurate as possible, you, the doctor, and staff conducting the study will not know if you are being given the investigational drug or the placebo (unless there is an emergency).
- Your total participation in the study will be for approximately 71 weeks (18 months), including screening for eligibility, study treatment, and follow-up.
- During the first 3 weeks of the study treatment period, you will receive two injections of the study drug. After that, you will receive an injection of the study drug every month for the next 42 weeks.
A
A
Would you like to know more about the GOLDEN study?
